NASDAQ:ARQT | Cash Flow Statement | Arcutis Biotherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$15.01M
2026-03-31-$11.3M$2.24M$0.00-$11.33M$1.07M
2025-12-31$17.4M$26.19M$0.00-$34.18M$3.72M
2025-09-30$7.41M
2025-06-30-$15.89M
2025-03-31-$25.06M-$30.38M$608,000.00$11.75M$395,000.00
2024-12-31-$10.79M-$748,000.00$0.00$34.88M-$97.41M
2024-09-30-$41.54M
2024-06-30-$52.33M
2024-03-31-$35.38M-$31.6M$0.00-$28.7M$161.76M
2023-12-31-$66.28M-$56.24M$6,000.00-$62.19M$99.29M
2023-09-30-$44.77M
2023-06-30-$70.99M
2023-03-31-$80.1M-$80.34M$82,000.00$107.75M$100,000.00
2022-12-31-$72.02M-$71.07M$123,000.00$42.2M$962,000.00
2022-09-30-$107.71M
2022-06-30-$67.41M
2022-03-31-$64.32M-$56.98M$124,000.00$15.3M$14.72M
2021-12-31-$71.33M-$51.71M$261,000.00$23.5M$72.88M
2021-09-30-$56.98M
2021-06-30-$42.01M
2021-03-31-$36.04M-$46.2M$554,000.00$62M$207.82M
2020-12-31-$34.05M-$32.57M$153,000.00-$75.89M$129.38M
2020-09-30-$38.2M
2020-06-30-$35.41M
2020-03-31-$28.01M-$21.01M$41,000.00-$20.33M$168.89M
2019-12-31-$12.57M-$16.8M$66,000.00-$36M$92.96M
2019-09-30-$14.48M
2019-06-30-$8.29M
2019-03-31-$6.66M-$7.07M$183,000.00-$9.27M$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$16.14M-$5.63M$686,000.00-$30.25M$6.97M
2024-12-31-$140.04M-$112.16M$143,000.00$28.82M$66.2M
2023-12-31-$262.14M-$247.06M$428,000.00$180.23M$101.32M
2022-12-31-$311.46M-$257.72M$333,000.00-$87.2M$301.8M
2021-12-31-$206.36M-$174.63M$995,000.00-$75.95M$281.95M
2020-12-31-$135.68M-$113.03M$321,000.00-$181.82M$298.15M
2019-12-31-$42M-$42.84M$295,000.00-$26.33M$93.1M
2018-12-31-$19.26M-$14.09M$0.00-$11.53M$61.59M